{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:45:41Z","timestamp":1770842741974,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST-108\\u20132113-M-007\\u2013023- MY2"],"award-info":[{"award-number":["MOST-108\\u20132113-M-007\\u2013023- MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSC-110\\u20132113-M-007\\u2013014"],"award-info":[{"award-number":["NSC-110\\u20132113-M-007\\u2013014"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSC-106\\u20132113-M-007\\u2013012-"],"award-info":[{"award-number":["NSC-106\\u20132113-M-007\\u2013012-"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSC-112\\u20132113-M-007\\u2013014"],"award-info":[{"award-number":["NSC-112\\u20132113-M-007\\u2013014"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSC-107\\u20132113-M-007\\u2013025"],"award-info":[{"award-number":["NSC-107\\u20132113-M-007\\u2013025"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSC-109\\u20132113-M-007\\u2013016"],"award-info":[{"award-number":["NSC-109\\u20132113-M-007\\u2013016"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bmcl.2024.129744","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:16:35Z","timestamp":1712823395000},"page":"129744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fluorine-18 labeling PEGylated 6-boronotryptophan for PET scanning of mice for assessing the pharmacokinetics for boron neutron capture therapy of brain tumors"],"prefix":"10.1016","volume":"105","author":[{"given":"Xiang-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwei-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng-San","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiou-Shiow","family":"Farn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Jiun","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Shan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2024.129744_b0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmcl.2024.129744_b0010","doi-asserted-by":"crossref","first-page":"iii1-iii38","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.bmcl.2024.129744_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New England J Med"},{"issue":"3","key":"10.1016\/j.bmcl.2024.129744_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030324","article-title":"Current FDA-approved therapies for high-grade malignant gliomas","volume":"9","author":"Fisher","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bmcl.2024.129744_b0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","article-title":"A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv"},{"issue":"11","key":"10.1016\/j.bmcl.2024.129744_b0030","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","article-title":"Boron neutron capture therapy of cancer: Current status and future prospects","volume":"11","author":"Barth","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.bmcl.2024.129744_b0035","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/glia.23309","article-title":"Glioma infiltration and extracellular matrix: key players and modulators","volume":"66","author":"Ferrer","year":"2018","journal-title":"Glia"},{"issue":"136","key":"10.1016\/j.bmcl.2024.129744_b0040","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0490","article-title":"The biology and mathematical modelling of glioma invasion: a review","volume":"14","author":"Alfonso","year":"2017","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.bmcl.2024.129744_b0045","first-page":"6","article-title":"The human SLC7A5 (LAT1): the intriguing histidine\/large neutral amino acid transporter and its relevance to human health","author":"Scalise","year":"2018","journal-title":"Front Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2024.129744_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102428","article-title":"The L-Type Amino Acid Transporter LAT1An Emerging Target in Cancer","volume":"20","author":"H\u00e4fliger","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.129744_b0055","first-page":"8","article-title":"Review of the correlation of LAT1 with diseases: mechanism and treatment","author":"Zhang","year":"2020","journal-title":"Front Chem"},{"issue":"7757","key":"10.1016\/j.bmcl.2024.129744_b0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"7391","key":"10.1016\/j.bmcl.2024.129744_b0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bmcl.2024.129744_b0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10147-019-01480-4","article-title":"Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era","volume":"25","author":"Suzuki","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.bmcl.2024.129744_b0075","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun"},{"key":"10.1016\/j.bmcl.2024.129744_b0080","series-title":"In Status of Accelerator-Based BNCT Projects Worldwide, 25th International Conference on the Application of Accelerators in Research and Industry (CAARI), Grapevine, TX, Aug 12\u201317","author":"Kiyanagi","year":"2018"},{"key":"10.1016\/j.bmcl.2024.129744_b0085","article-title":"Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)","volume":"24","author":"Hughes","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.bmcl.2024.129744_b0090","first-page":"11","article-title":"Boron neutron capture therapy: a review of clinical applications","author":"Malouff","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2024.129744_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.apradiso.2013.11.109","article-title":"Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)","volume":"88","author":"Moss","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.bmcl.2024.129744_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/molecules25040828","article-title":"Boron chemistry for medical applications","volume":"25","author":"Ali","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129744_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bmcl.2024.129744_b0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/acsmedchemlett.0c00064","article-title":"Boron accumulation in brain tumor cells through boc-protected tryptophan as a carrier for boron neutron capture therapy","volume":"11","author":"Chio","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmcl.2024.129744_b0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.bmcl.2024.129744_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG - A versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.bmcl.2024.129744_b0125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/acs.biomac.8b00083","article-title":"The Effect of Molecular Structure on Cytotoxicity and Antitumor Activity of PEGylated Nanomedicines","volume":"19","author":"Lin","year":"2018","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.bmcl.2024.129744_b0130","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1021\/nn5061578","article-title":"Engineering Poly(ethylene glycol) Particles for Improved Biodistribution","volume":"9","author":"Cui","year":"2015","journal-title":"ACS Nano"},{"issue":"128","key":"10.1016\/j.bmcl.2024.129744_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci Transl Med"},{"issue":"26","key":"10.1016\/j.bmcl.2024.129744_b0140","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1039\/C5PY00569H","article-title":"Synthesis of an acid-labile polymeric prodrug DOX-<i>acetal<\/i>-PEG-<i>acetal<\/i>-DOX with high drug loading content for pH-triggered intracellular drug release","volume":"6","author":"Wang","year":"2015","journal-title":"Polym Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2024.129744_b0145","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1039\/C7PY02108A","article-title":"A pH-responsive polymer based on dynamic imine bonds as a drug delivery material with pseudo target release behavior","volume":"9","author":"Tao","year":"2018","journal-title":"Polym Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2024.129744_b0150","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/acs.chemrev.8b00006","article-title":"Designing smart polymer conjugates for controlled release of payloads","volume":"118","author":"Seidi","year":"2018","journal-title":"Chem Rev"},{"issue":"12","key":"10.1016\/j.bmcl.2024.129744_b0155","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.cclet.2019.04.052","article-title":"Facile preparation of pH-responsive PEGylated prodrugs for activated intracellular drug delivery","volume":"30","author":"Song","year":"2019","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129744_b0160","first-page":"11","article-title":"Schiff-linked PEGylated doxorubicin prodrug forming pH-responsive nanoparticles with high drug loading and effective anticancer therapy","author":"Song","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2024.129744_b0165","first-page":"194","article-title":"ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy","author":"Pan","year":"2020","journal-title":"Colloids and Surfaces B-Biointerfaces"},{"issue":"1","key":"10.1016\/j.bmcl.2024.129744_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.7447","article-title":"Prospective of <SUP>68<\/SUP>Ga-Radiopharmaceutical Development","volume":"4","author":"Velikyan","year":"2014","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bmcl.2024.129744_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","article-title":"The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Umbehr","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.bmcl.2024.129744_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010093","article-title":"Recent development of radiofluorination of boron agents for boron neutron capture therapy of tumor: creation of <SUP>18<\/SUP>F-Labeled C-F and B-F Linkages","volume":"16","author":"Deng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2024.129744_b0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jfluchem.2006.01.011","article-title":"Fluorine in medicinal chemistry: A review of anti-cancer agents","volume":"127","author":"Isanbor","year":"2006","journal-title":"J Fluor Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2024.129744_b0190","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med Res Rev"},{"issue":"16","key":"10.1016\/j.bmcl.2024.129744_b0195","article-title":"Optimizing boron neutron capture therapy (BNCT) to treat cancer: an updated review on the latest developments on boron compounds and strategies","volume":"15","author":"Hughes","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bmcl.2024.129744_b0200","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acs.chemrev.5b00493","article-title":"<SUP>18<\/SUP>F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography","volume":"116","author":"Preshlock","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2024.129744_b0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2017.07.019","article-title":"Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma","volume":"107","author":"Yeh","year":"2017","journal-title":"Eur J Pharm Sci"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T02:53:23Z","timestamp":1716951203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2400146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0960894X2400146X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129744","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorine-18 labeling PEGylated 6-boronotryptophan for PET scanning of mice for assessing the pharmacokinetics for boron neutron capture therapy of brain tumors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129744"}}